1. Home
  2. BFRI vs TRIB Comparison

BFRI vs TRIB Comparison

Compare BFRI & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.14

Market Cap

13.2M

Sector

Health Care

ML Signal

HOLD

TRIB

Trinity Biotech plc

HOLD

Current Price

$0.61

Market Cap

14.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BFRI
TRIB
Founded
1997
1992
Country
United States
Ireland
Employees
94
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
14.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
BFRI
TRIB
Price
$1.14
$0.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
121.5K
88.2K
Earning Date
05-13-2026
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.36
$13.51
Revenue Next Year
$16.98
$13.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$0.50
52 Week High
$1.19
$3.44

Technical Indicators

Market Signals
Indicator
BFRI
TRIB
Relative Strength Index (RSI) 64.13 38.69
Support Level $0.79 $0.50
Resistance Level $1.17 $0.76
Average True Range (ATR) 0.07 0.04
MACD -0.00 -0.01
Stochastic Oscillator 73.68 1.06

Price Performance

Historical Comparison
BFRI
TRIB

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

Share on Social Networks: